Steven Pilewski joins RQM+ as Chief Operating Officer of Laboratory Services
RQM+, one of the leading MedTech service providers, yesterday announced the appointment of Steven Pilewski as Chief Operating Officer of its Laboratory Services business unit, which provides chemical characterization and reverse chemical engineering (or “deformulation”) of complex products, as well as contaminant and failure investigations for MedTech manufacturers. The business unit was founded more than 4 […]
Rxilient Biotech and Junshi Biosciences partner to develop and commercialize Toripalimab
On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that two parties will form a joint venture to develop and commercialize toripalimab in Thailand, Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, the Philippines, and Vietnam. Toripalimab is an anti-PD-1 monoclonal antibody independently developed by Junshi Biosciences. […]
Escient Pharmaceuticals unveils USD120 million series C financing
Escient Pharmaceuticals, a clinical-stage company advancing novel small molecule therapeutics for the potential treatment of a broad range of neurosensory-inflammatory disorders, today announced the closing of a $120 million Series C financing. The financing was co-led by NEA, Abingworth, and Forge Life Science Partners with participation from other new investors Avego, PFM Health Sciences, and […]
VISEO Acquires Scanomi powers digital transformation in APJ region
VISEO, a global IT company specializing in digital transformation services, and Scanomi, a leading Anaplan Gold partner in Asia,recently announced that they are going to join forces. The acquisition will enhance the ability of both companies to deploy larger-scale digital projects across the APJ region. Scanomi is an Anaplan Gold Partner company specializing in managing […]
Oaktree Capital Management approves new term loan for Innocoll
Innocoll Biotherapeutics plc, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, announced recently the successful refinancing of its existing term loan facility with a new $125 million term loan provided by funds managed by Oaktree Capital Management, L.P. (“Oaktree”). As per reports, the new term loan meaningfully strengthens Innocoll’s financial flexibility and […]